Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4
- PMID: 6277788
- PMCID: PMC350925
- DOI: 10.1128/iai.34.3.684-692.1981
Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4
Abstract
Monoclonal antibodies were prepared against herpes simplex virus type 1 (strain 14012) by two immunization procedures. Procedure A utilized infectious virus propagated in mouse cells, and procedure B utilized mouse cells infected with herpes simplex virus in the presence of cycloheximide and harvested 1 h after removal of the inhibitor. A total of 52 monoclonal antibodies were obtained against 10 herpes simplex virus proteins, including four glycosylated proteins (a 110,000-molecular-weight protein, gB, gC, and gD) and six nonglycosylated proteins (a 68,000-molecular-weight protein, ICP 9, ICP 8, ICP 6, ICP 5, and the immediate-early ICP 4). The antibodies were assayed against herpes simplex virus types 1 and 2 by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of radioimmunoprecipitates, immunofluorescence, and neutralization. Using the reagents prepared, we concluded that the 110,000-molecular-weight protein, gD, ICP 9, ICP 9, ICP 6, and the 68,000-molecular-weight protein express both type-specific and cross-reactive antigenic determinants. In contrast, nine antibodies against gB all cross-reacted with herpes simplex virus type 2, whereas eight antibodies to gC all reacted type specifically.
Similar articles
-
Inhibition of glycosylation of herpes simplex virus glycoproteins: identification of antigenic and immunogenic partially glycosylated glycopeptides on the cell surface membrane.Virology. 1983 Apr 15;126(1):1-18. doi: 10.1016/0042-6822(83)90458-0. Virology. 1983. PMID: 6189286
-
Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease.Infect Immun. 1981 Oct;34(1):192-9. doi: 10.1128/iai.34.1.192-199.1981. Infect Immun. 1981. PMID: 6271681 Free PMC article.
-
Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity.J Virol. 1985 Dec;56(3):930-7. doi: 10.1128/JVI.56.3.930-937.1985. J Virol. 1985. PMID: 2415719 Free PMC article.
-
Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.J Immunol. 1984 Oct;133(4):2206-14. J Immunol. 1984. PMID: 6206157
-
Herpes simplex virus antigens and antibodies: a survey of studies based on quantitative immunoelectrophoresis.Rev Infect Dis. 1980 Nov-Dec;2(6):899-913. doi: 10.1093/clinids/2.6.899. Rev Infect Dis. 1980. PMID: 6164087 Review.
Cited by
-
Selective recruitment of host factors by HSV-1 replication centers.Dongwuxue Yanjiu. 2015 May 18;36(3):142-51. Dongwuxue Yanjiu. 2015. PMID: 26018857 Free PMC article.
-
DNA binding by the herpes simplex virus type 1 ICP4 protein is necessary for efficient down regulation of the ICP0 promoter.J Virol. 1989 Jun;63(6):2497-503. doi: 10.1128/JVI.63.6.2497-2503.1989. J Virol. 1989. PMID: 2542567 Free PMC article.
-
Proteomic analysis of the herpes simplex virus 1 virion protein 16 transactivator protein in infected cells.Proteomics. 2015 Jun;15(12):1957-67. doi: 10.1002/pmic.201500020. Epub 2015 Apr 29. Proteomics. 2015. PMID: 25809282 Free PMC article.
-
Localization of epitopes of herpes simplex virus type 1 glycoprotein D.J Virol. 1985 Feb;53(2):634-44. doi: 10.1128/JVI.53.2.634-644.1985. J Virol. 1985. PMID: 2578577 Free PMC article.
-
Functional relevance of specific interactions between herpes simplex virus type 1 ICP4 and sequences from the promoter-regulatory domain of the viral thymidine kinase gene.J Virol. 1990 Jun;64(6):2620-31. doi: 10.1128/JVI.64.6.2620-2631.1990. J Virol. 1990. PMID: 2159535 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
